Viraforce

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

ascorbic acid, Quantity: 250 mg; zinc glycinate, Quantity: 26.1 mg (Equivalent: zinc, Qty 8 mg); Olea europaea, Quantity: 125 mg (Equivalent: Olea europaea, Qty 1.25 g); Lonicera japonica, Quantity: 100 mg (Equivalent: Lonicera japonica, Qty 1 g); Echinacea purpurea, Quantity: 125 mg (Equivalent: Echinacea purpurea, Qty 750 mg); Andrographis paniculata, Quantity: 200 mg

Disponible depuis:

McPherson's Consumer Products Pty Ltd

forme pharmaceutique:

Capsule, hard

Composition:

Excipient Ingredients: colloidal anhydrous silica; croscarmellose sodium; magnesium stearate; maltodextrin; calcium carbonate; hypromellose; disodium edetate; potable water; potassium acetate; gellan gum

Mode d'administration:

Oral

indications thérapeutiques:

Maintain/support healthy immune system function ; Maintain/support immune system to fight illness ; Decrease/reduce/relieve symptoms of common colds and flu (Linked Indication:Relieve weariness/tiredness/fatigue/feeling of weakness; Antipyretic/febrifuge/relieve mild fever/reduce body temperature/body cooling; Decrease/reduce/relieve disturbed/restless sleep; Decrease/reduce/relieve cough; Relieve runny/dripping nose); Decrease/reduce/relieve the severity of symptoms of mild upper respiratory tract infections (Linked Indication:Relieve weariness/tiredness/fatigue/feeling of weakness; Antipyretic/febrifuge/relieve mild fever/reduce body temperature/body cooling; Decrease/reduce/relieve disturbed/restless sleep; Decrease/reduce/relieve cough; Relieve runny/dripping nose); Relieve symptoms of sore throat/pharyngitis

Descriptif du produit:

Visual Identification: ;

Statut de autorisation:

Listed

Date de l'autorisation:

2020-04-24